Mostrando resultados 132 a 151 de 163
< Anterior
Siguiente >
| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| openAccess | | oct-2023 | Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients | Puertas Martínez, Borja; González-Calle, Verónica; Sureda, Anna; Moreno, María José; Oriol, Albert; González, Esther; Rosiñol, Laura; López, Jordi; Escalante, Fernando; Martínez-López, Joaquín; Carrillo Cruz, Estrella; Clavero, Esther; Ríos-Tamayo, R.; Rey-Bua, Beatriz; Gonzalez-Rodriguez, Ana Pilar; Dourdil, Mª Victoria; Arriba, Felipe de; González, Sonia; Pérez de Oteyza, Jaime; Hernandez, Miguel T.; García-Mateo, Aránzazu; Bargay, Joan; Bladé, Joan; Lahuerta, Juan José; San Miguel, Jesús F. CSIC ORCID; Ocio, Enrique M. CSIC ORCID ; Mateos, Maria Victoria | artículo |
| closedAccess |  | jul-2022 | Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem-cell transplantation is a prognostic marker of longer progression-free survival and overall survival | Dávila, Julio; González-Calle, Verónica; Escalante, Fernando; Cerdá, Seila; Puig, Noemi; García-Sanz, Ramón; Bárez, Abelardo; Montes, Carmen; López, Rosa CSIC ORCID ; Alonso, José María; Aguilar, Carlos; García-Mateo, Aránzazu; Labrador, Jorge; Aguilera, Carmen; García-Coca, Alfonso; Hernández, Roberto; Mateos, Maria Victoria; Ocio, Enrique M. CSIC ORCID | artículo |
| openAccess |  | 30-sep-2021 | Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma | Puig, Noemi; Flores-Montero, Juan; Burgos, Leire; Cedena, Maria-Teresa; Cordón, Lourdes; Pérez, José J.; Sanoja-Flores, Luzalba CSIC ORCID; Manrique, Irene; Rodríguez-Otero, Paula; Rosiñol, Laura; Martínez-López, Joaquín; Mateos, Maria Victoria; Lahuerta, Juan José; Bladé, Joan; San Miguel, Jesús F. CSIC ORCID; Orfao, Alberto CSIC ORCID ; Paiva, Bruno | artículo |
| closedAccess |  | sep-2019 | Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma | López-Corral, L.; Caballero-Velázquez, Teresa CSIC ORCID; López-Godino, Oriana; Rosiñol, Laura; Pérez-Vicente, Sabina CSIC; Fernández-Avilés, Francisco; Krsnik, Isabel; Morillo, Daniel; Heras, Inmaculada; Morgades, Mireia; Rifon, Jose J.; Sampol, Antonia; Iniesta, Francisca; Ocio, Enrique M. CSIC ORCID ; Martín, Jesús; Rovira, Montserrat; Cabero, Martín; Castilla-Llorente, Cristina; Ribera, Josep-Maria; Torres-Juan, Marta; Moraleda, José María; Martínez, Carmen; Vázquez, Alejandro; Gutiérrez, Gonzalo; Caballero, Maria Dolores; San Miguel, Jesús F. CSIC ORCID; Mateos, Maria Victoria; Pérez-Simón, José A. CSIC ORCID | artículo |
| closedAccess |  | 2011 | Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib–melphalan–prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study | Dimopoulos, Meletios A.; Mateos, Maria Victoria; Richardson, Paul G.; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2009 | Risk stratification in the era of novel therapies | San Miguel, Jesús F. CSIC ORCID; Mateos, Maria Victoria; Gutiérrez, Norma Carmen | artículo |
| closedAccess |  | 20-jun-2019 | Role of urine immunofixation in the complete response assessment of MM patients other than light-chain-only disease | Lahuerta, Juan José; Jiménez-Ubieto, Ana; Paiva, Bruno; Martínez-López, Joaquín; González-Medina, José; López-Anglada, Lucía; Cedena, Maria-Teresa; Puig, Noemi; Oriol, Albert; Blanchard, María Jesús; Ríos, Rafael; Martín, Jesús; Martínez, Rafael; Sureda, Anna; Hernandez, Miguel T.; Rubia, Javier de la; Krsnik, Isabel; Cabañas, Valentin; Palomera, Luis; Bargay, Joan; Mateos, Maria Victoria; Rosiñol, Laura; San Miguel, Jesús F. CSIC ORCID; Bladé, Joan | artículo |
| closedAccess |  | 2008 | Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy? | Mateos, Maria Victoria; García-Sanz, Ramón; Colado, Enrique; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2012 | SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status | López-Corral, L.; Sarasquete, María Eugenia; Beà, Silvia; García-Sanz, Ramón; Mateos, Maria Victoria; Bladé, Joan; González, Marcos CSIC ORCID ; Hernández, Jesús M. CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID; Gutiérrez, Norma Carmen | artículo |
| openAccess |  | 2011 | SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies: from MGUS to myeloma status | López-Corral, L.; Sarasquete, María Eugenia; Beà, Silvia; García-Sanz, Ramón; Mateos, Maria Victoria; Bladé, Joan; González, Marcos CSIC ORCID ; Hernández, Jesús M. CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID; Gutiérrez, Norma Carmen | presentación |
| openAccess |  | 2020 | Subcutaneous versus intravenous daratumumab in multiple myeloma – Authors' reply | Mateos, Maria Victoria; Usmani, Saad Z. | artículo |
| closedAccess |  | 2010 | Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone | Harousseau, Jean-Luc; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess | | abr-2022 | Supplementary files of the article Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial [Dataset] | Terpos, Evangelos; Dimopoulos, Meletios A.; Boccadoro, Mario; Delimpasi, Sosana; Beksac, Meral; Katodritou, Eirini; Moreau, Philippe; Pompa, Alessandra; Symeonidis, Argiris; Bila, Jelena; Oriol, Albert; Mateos, Maria Victoria; Einsele, Hermann; Orfanidis, Ioannis; Gries, Katharine S.; Fastenau, John; Liu, Kevin; He, Jianming; Kampfenkel, Tobias; Qiu, Yanping; Amin, Himal; Carson, Robin; Sonneveld, Pieter | dataset |
| openAccess |  | 21-oct-2022 | Supplementary materials of the aticle NGS-Based molecular karyotyping of multiple myeloma: results from the GEM12 clinical trial [Dataset] | Rosa-Rosa, Juan Manuel; Cuenca, Isabel; Medina, Alejandro; Vázquez, Iria; Sánchez de la Cruz, Andrea; Buenache, Natalia; Sánchez, Ricardo; Jiménez, Cristina; Rosiñol, Laura; Gutiérrez, Norma Carmen; Ruiz-Heredia, Yanira; Barrio, Santiago; Oriol, Albert; Martín-Ramos, María-Luisa; Blanchard, María Jesús; Ayala Bueno, Rosa CSIC ORCID; Ríos-Tamayo, R.; Sureda, Anna; Hernandez, Miguel T.; Rubia, Javier de la; Alkorta-Aranburu, Gorka; Agirre, Xavier; Bladé, Joan; Mateos, Maria Victoria; Lahuerta, Juan José; San-Miguel, Jesús; Calasanz, Mª Jose; García-Sanz, Ramón; Martínez-López, Joaquín | dataset |
| closedAccess |  | 2021 | Survival prediction and treatment optimization of multiple myeloma patients using machine-learning models based on clinical and gene expression data | Mosquera Orgueira, Adrián; González Pérez, Marta Sonia; Díaz, José Ángel; Antelo Rodríguez, Beatriz; Alonso Vence, Natalia; Bendaña López, Ángeles; Abuín Blanco, Aitor; Bao Pérez, Laura; Peleteiro Raíndo, Andrés; Cid López, Miguel; Pérez-Encinas, Manuel; Bello López, José Luis; Mateos, Maria Victoria | artículo |
| closedAccess |  | 27-ene-2022 | Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE | San-Miguel, Jesús; Avet-Loiseau, Hervé; Paiva, Bruno; Kumar, Sumit; Dimopoulos, Meletios A.; Facon, Thierry; Mateos, Maria Victoria; Touzeau, Cyrille; Jakubowiak, Andrzej J.; Usmani, Saad Z.; Cook, Gordon; Cavo, Michele; Quach, Hang; Ukropec, Jon; Ramaswami, Priya; Pei, Huiling; Qi, Mia; Sun, Steven; Wang, Jianping; Krevvata, Maria; DeAngelis, Nikki; Heuck, Christoph; Van Rampelbergh, Rian; Kudva, Anupa; Kobos, Rachel; Qi, Ming; Bahlis, Nizar J. | artículo |
| closedAccess | | jul-2023 | Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma | Mateos, Maria Victoria; Rigaudeau, Sophie; Basu, Supratik; Špička, Ivan; Schots, Rik; Wrobel, Tomasz; Cook, Gordon; Beksac, Meral; Gries, Katharine S.; Kudva, Anupa; Tromp, Brenda; Rampelbergh, Rian Van; Pei, Huiling; Wroblewski, Susan; Carson, Robin; Delioukina, María; White, Darrell | artículo |
| openAccess |  | 2017 | Synergistic DNA-damaging effect in multiple myeloma with the combination of zalypsis, bor tezomib and dexamethasone | López-Iglesias, Ana-Alicia; González-Méndez, Lorena; San-Segundo, Laura CSIC; Herrero, Ana B. CSIC ORCID; Hernández-García, Susana CSIC; Martín-Sánchez, Montserrat; Gutiérrez, Norma Carmen; Paíno, Teresa CSIC ORCID; Avilés Marín, Pablo; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID | artículo |
| closedAccess |  | 2015 | The cellular origin and malignant transformation of Waldenström macroglobulinemia | Paiva, Bruno; Corchete, Luis A.; Vidriales, Maria Belén; García-Sanz, Ramón; Pérez, José J.; Aires-Mejia, I.; Sánchez, Maria Luz; Bárcena, Paloma; Jiménez, Cristina; Sarasquete, María Eugenia; Mateos, Maria Victoria; Ocio, Enrique M. CSIC ORCID ; Puig, Noemi; García de Coca, Alfonso; Orfao, Alberto CSIC ORCID ; Gutiérrez, Norma Carmen; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2011 | The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis | Paiva, Bruno; Vidriales, Maria Belén; García-Sanz, Ramón; Ocio, Enrique M. CSIC ORCID ; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID | artículo |
